Medicare Enrolled
Dr. Paul Yoshino, M.D.
Interventional Cardiology · Downey, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yoshino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yoshino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yoshino
Dr. Paul Yoshino is an interventional cardiology specialist in Downey, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yoshino performed 1,344 Medicare services across 968 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yoshino received a total of $8,663 from 38 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yoshino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 1,344 Medicare services
$8,663 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,344
Medicare services
Bottom 34% in CA for interventional cardiology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
968
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
220 | $42 | $135 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $98 | $245 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
110 | $76 | $222 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
106 | $158 | $513 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
103 | $68 | $159 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
101 | $11 | $44 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
89 | $7 | $35 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
68 | $111 | $281 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
55 | $415 | $1,091 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
55 | $1 | $10 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
54 | $56 | $192 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
51 | $145 | $394 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
47 | $80 | $199 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
38 | $89 | $243 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $67 | $167 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
20 | $23 | $76 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $22 | $59 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
18 | $796 | $1,571 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.5% high complexity
32.7% medium
53.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,663
Total received (2018-2024)
Avg $1,238/year across 7 years
Top 43% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,663 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,809
2023
$1,197
2022
$1,120
2021
$1,004
2020
$330
2019
$936
2018
$2,266
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$420
Lexicon Pharmaceuticals, Inc.
$193
Merck Sharp & Dohme LLC
$186
PFIZER INC.
$168
Medtronic, Inc.
$114
Novartis Pharmaceuticals Corporation
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
BIOTRONIK INC.
$82
Janssen Pharmaceuticals, Inc
$82
SCPHARMACEUTICALS INC.
$63
Abbott Laboratories
$62
AstraZeneca Pharmaceuticals LP
$58
Kiniksa Pharmaceuticals International, plc
$47
Boston Scientific Corporation
$35
Edwards Lifesciences Corporation
$31
Novo Nordisk Inc
$23
Regeneron Healthcare Solutions, Inc.
$22
CVRx, Inc.
$22
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,513
PFIZER INC.
$771
Novartis Pharmaceuticals Corporation
$656
SANOFI-AVENTIS U.S. LLC
$647
Janssen Pharmaceuticals, Inc
$569
Medtronic Vascular, Inc.
$566
Abbott Laboratories
$406
Boehringer Ingelheim Pharmaceuticals, Inc.
$386
Merck Sharp & Dohme LLC
$317
AstraZeneca Pharmaceuticals LP
$316
E.R. Squibb & Sons, L.L.C.
$295
Amgen Inc.
$269
BIOTRONIK INC.
$257
Lexicon Pharmaceuticals, Inc.
$240
Boston Scientific Corporation
$214
Gilead Sciences, Inc.
$203
Medtronic, Inc.
$157
Merck Sharp & Dohme Corporation
$118
SCPHARMACEUTICALS INC.
$103
Kestra Medical Technology Services, Inc.
$101
Edwards Lifesciences Corporation
$90
Esperion Therapeutics, Inc.
$69
Kiniksa Pharmaceuticals International, plc
$47
Regeneron Healthcare Solutions, Inc.
$46
Philips Electronics North America Corporation
$39
Tactile Systems Technology Inc
$30
Kiniksa Pharmaceuticals, Ltd.
$29
ABIOMED
$23
HeartFlow, Inc.
$23
Novo Nordisk Inc
$23
Actelion Pharmaceuticals US, Inc.
$23
CVRx, Inc.
$22
Baxter Healthcare
$19
BOSTON SCIENTIFIC CORPORATION
$18
GE HEALTHCARE
$17
Amarin Pharma Inc.
$15
Allergan Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AVEIR · Arcalyst · Assure WCD · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · COREVALVE EVOLUT R · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edora 8 DR-T · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · Hillrom - Cardiac Ambulatory Monitor · IGT D Coronary · INVOKANA · Impella · Inpefa · JARDIANCE · LATITUDE · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MULTAQ · Micra · NEXLETOL · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · Pacemakers · Quartet CRT Lead · Repatha · Resolute · Reveal LINQ · SAPIEN 3 Ultra RESILIA · VARITHENA · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
114
Per 100K population
1.2
County median income
$87,760
Nearest hospital
PIH HEALTH DOWNEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yoshino is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yoshino experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Yoshino performed 220 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yoshino receive payments from pharmaceutical companies?
Yes. Dr. Yoshino received a total of $8,663 from 38 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yoshino's costs compare to other interventional cardiologists in Downey?
Dr. Yoshino's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yoshino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Downey
Browse interventional cardiologists in Downey ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology